Personal and Home Care Products
CIRS Group
Medical Devices
C&K Testing
Carbon Neutrality

SCCS Issued Final Opinion on the Safety of Benzophenone-4

from CIRS by

On April 4, 2024, the Scientific Committee on Consumer Safety (SCCS) of the European Union issued a final opinion on Benzophenone-4(SCCS/1660/23). The preliminary opinion was released on December 15, 2023.


The SCCS concludes the following:

1. In light of the data provided and taking under consideration the concerns related to the potential endocrine disrupting properties of benzophenone-4, does the SCCS consider benzophenone-4 safe when used as a UV-Filter in cosmetic products up to a maximum concentration of 5%?

On the basis of the safety assessment, and considering the concerns related to potential endocrine-disrupting properties, the SCCS is of the opinion that benzophenone-4 is safe when used as UV filter up to a maximum concentration of 5% in sunscreen, face and hand cream, all leave-on and rinse-off products (total dermal aggregate), lipstick, sunscreen propellant spray and pump spray, when used separately or in combination (based on deterministic aggregated exposure).

2. Alternatively, what is according to the SCCS the maximum concentration considered safe for the use of benzophenone-4 in cosmetic products?

Any additional use of benzophenone-4, such as protectant for stabilising cosmetic formulations when exposed to light, should remain within the concentration mentioned above (i.e. 5%), including the use as UV-filter.

3. Does the SCCS have any further scientific concerns with regard to the use of benzophenone-4 in cosmetic products?

The SCCS mandates do not address environmental aspects. Therefore, this assessment did not cover the safety of benzophenone-4 for the environment.

If you need any assistance or have any questions, please get in touch with us via



We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.

Contact Us
+353 1 477 3710 (EU)
+44 20 3239 9430 (UK)
+1 703 520 1420 (USA)
+86 571 8720 6574 (CN)
+82 2 6347 8816 (KR)